Skip to search formSkip to main contentSkip to account menu

lansoprazole

Known as: 2-(((3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl)methyl)sulfinyl)benzimidazole, Lansoprazole [Chemical/Ingredient], Lansoprazoles 
A substituted benzimidazole prodrug with selective and irreversible proton pump inhibitor activity. Lansoprazole prodrug is converted to an active… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2014
Highly Cited
2014
Drug‐induced subacute cutaneous lupus erythematosus (SCLE) has been known in the literature since 1985 and is increasingly… 
Highly Cited
2012
Highly Cited
2012
Increased resistance of Helicobacter pylori to antibiotics has increased the need to develop new first‐line treatments for H… 
Review
2003
Review
2003
Introduction. For the eradication of Helicobacter pylori a 1‐week triple therapy combining proton pump inhibitors with two… 
Highly Cited
2003
Highly Cited
2003
Background:  An antimicrobial susceptibility test for Helicobacter pylori before second‐line treatment is often performed… 
Highly Cited
2002
Highly Cited
2002
Background. One week of quadruple therapy including metronidazole is recommended for Helicobacter pylori treatment failures after… 
Highly Cited
1999
Highly Cited
1999
Background. Data regarding the effectiveness of second‐line treatment of Helicobacter pylori infection are limited, especially if… 
Highly Cited
1998
Highly Cited
1998
One‐week triple therapies have been endorsed as the treatment regimens of choice for eradication of Helicobacter pylori infection…